Trial intelligence / Profile preview

V120083 in osteoarthritis of the knee

NCT03028870Phase 2Completed

Sponsor
Purdue Pharma
Start
Mar 2017
Primary completion
Nov 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of S-120083 in osteoarthritis (OA), sponsored by Purdue Pharma. Started Mar 2017; status: completed.

02

Drugs

S-120083
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT03028870.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03028870.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call